Generate a tailored SOP for Dr. Nikolaos Stergiopoulos. Improve your application with a focused, well-structured draft.
Nikolaos Stergiopoulos is a full professor at the Swiss Federal Institute of Technology Lausanne (EPFL), where he has been directing the Laboratory of Hemodynamics and Cardiovascular Technology (LHCT) since 2002. His research focuses on arterial wall mechanics, vascular remodeling, atherogenesis, restenosis, arterial wave propagation, and cardiac mechanics. He is also actively involved in the development of medical technologies, including angioplasty and stenting, and implantable devices to enhance cardiovascular health. His career includes founding and directing Rheon Medical SA and Antlia S.A. and serving as a scientific director at EndoArt S.A., showcasing his dedication to bridging academic research and clinical applications.
Swiss Federal Institute of Technology Lausanne • Lausanne, Switzerland
Director of the Laboratory of Hemodynamics and Cardiovascular Technology.
Rheon Medical SA • Préverenges, Switzerland
Focused on advancing medical technologies.
Antlia S.A. • EPFL campus, Switzerland
Involved in research and development in biomedical engineering.
EndoArt S.A. • Lausanne, Switzerland
Led scientific efforts in developing innovative medical solutions.
Swiss Federal Institute of Technology Lausanne • Lausanne, Switzerland
Contributed to the burgeoning field of Biomedical Engineering.
Swiss Federal Institute of Technology Lausanne • Lausanne, Switzerland
Conducted research in biomedical applications.
Iowa State University • Ames, Iowa
Taught courses in Biomedical Engineering.
Master's programs at EPFL are generally taught in English, though some may include French components. GRE is recommended but not mandatory for most Master's programs.